FDA Approved: DEXLANSOPRAZOLE DELAYED RELEASE — Original Application (Upsher-Smith Laboratories, LLC)

View source ↗

Summary

FDA approved a generic dexlansoprazole delayed-release tablet by Upsher-Smith Laboratories, LLC under an original ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erosive Esophagitis
• Gastroesophageal Reflux Disease

Drugs mentioned

• Dexlansoprazole Delayed Release (dexlansoprazole)

Snippet

ORIG AP for DEXLANSOPRAZOLE DELAYED RELEASE (DEXLANSOPRAZOLE)